
Matthew Sparks, MD
@nephro_sparks
PD @DukeKidney & @VADurham|@RenalFellowNtwk|@ASNKidney Comm Dir|@NephJC|#NephMadness creator|#NSMC APD|@kidneynews|@Neph_SIM Ad Board|🏳️🌈ally
ID: 24415922
https://medicine.duke.edu/faculty/matthew-sparks-md 14-03-2009 19:26:46
48,48K Tweet
21,21K Followers
6,6K Following

KidneyCure Grant Recipient Feature: Samira Farouk, MD, MSCR youtu.be/7iP1nkidIJk?si…

Duke nephrology first year fellows and Matthew Sparks, MD took on #NKFClinicals in Boston this week!! Always the best time with this group. Duke Kidney National Kidney Foundation


MANY THANKS to the #NephMadness 2025 Executive Team - their energy and enthusiasm keeps the content timely, relevant, and engaging! Matthew Sparks, MD Anna Burgner MD MEHP NoWars Elena Cervantes Jeff Kott Ana Catalina Dia Waguespack Krithika Mohan bit.ly/40HGJsE


Should patients receiving induction for lupus nephritis receive pneumocystis jirovecii pneumonia (PJP) prophylaxis? See what these nephrologists and rheumatologists had to say. bit.ly/KN1704-07 Matthew Sparks, MD Alessandra Tomasi #ASNKidneyNews


High-potency #Statins may raise #AKI risk by 34% in the first 120 days of use, per CNODES data. Yet RCTs show no substantial impact on #ESRD progression. #Statins #KidneyHealth #CardioTwitter bit.ly/3R5Vcct Matthew Sparks, MD Tampa General Hospital American Heart Association


Just saw this pop up when searching for a citation 🤩 Truly one of my most treasured memories from fellowship yrs MDI Biological Lab Thank you Renal Fellow Network for the opportunity to share this ♥️. Matthew Sparks, MD #MarkZeidel #WilliamJeffrey #SYadlapalli renalfellow.org/2025/04/16/how…

Meta-analysis of 57 RCTs: #Statins slowed #eGFR decline by 0.41 mL/min/year. Still, no RCTs have #Kidney outcomes as a primary endpoint. “Renal protection remains unproven,” says Matthew Sparks, MD. bit.ly/449vbk2 #Nephrology #CKD #KidneyDisease Tampa General Hospital



May 2025 ASN Publications Kidney News kidneynews.org/view/journals/… CAR-T Cell Therapy for Autoimmune Diseases Wins NephMadness 2025 NephMadness AJKD Matthew Sparks, MD


CAR-T Cell Therapy wins #NephMadness 2025! Matthew Sparks, MD recaps this year's tournament and the thrilling matchup. bit.ly/KN1705-20 #ASNKidneyNews




Did we just wrap up #NephMadness 2025? Yes... Is it time to start planning #NephMadness 2026? YES! Share your ideas for next year's tournament! bit.ly/NM26Ideas Matthew Sparks, MD Anna Burgner MD MEHP NoWars Jeff Kott Ana Catalina Krithika Mohan Dia Waguespack @nephmadness


Did we just wrap up #NephMadness 2025? Yes... Is it time to start planning #NephMadness 2026? YES! Share your ideas for next year's tournament! bit.ly/NM26Ideas Matthew Sparks, MD Anna Burgner MD MEHP NoWars Jeff Kott Ana Catalina Krithika Mohan Dia Waguespack

Celebrating 7⃣ years of #NephSIM! nephsim.com 📈1.35 million views 🫘National Kidney Foundation #NephSIM Nephrons Y5 +Prelim Outcomes Kidney Medicine kidneymedicinejournal.org/article/S2590-… ⚡️ 55 cases, 27 infographics 🎨Comics Momen Abbasi Samira Farouk, MD, MSCR Rachel Hilburg, MD Matthew Sparks, MD #Nephrology


A call for the ages by Phil Elson



July 2025 ASN Kidney News: Gene Therapy Without a Vector: Harnessing the Wild-Type PKD1/2 Allele in ADPKD kidneynews.org/view/journals/… Matthew Sparks, MD Arash Ataei ASN Publications

